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Differentiation of hematopoietic stem cell and myeloid
populations by ATP is modulated by cytokines
CMV Barbosa1, CMMP Leon1, A Nogueira-Pedro1, F Wasinsk1, RC Arau´jo1, A Miranda1, AT Ferreira1 and EJ Paredes-Gamero*,1,2
Extracellular nucleotides are emerging as important regulators of inflammation, cell proliferation and differentiation in a variety
of tissues, including the hematopoietic system. In this study, the role of ATP was investigated during murine hematopoiesis. ATP
was able to reduce the percentage of hematopoietic stem cells (HSCs), common myeloid progenitors and granulocyte–
macrophage progenitors (GMPs), whereas differentiation into megakaryocyte–erythroid progenitors was not affected. In
addition, in vivo administration of ATP to mice reduced the number of GMPs, but increased the number of Gr-1þMac-1þ myeloid
cells. ATP also induced an increased proliferation rate and reduced Notch expression in HSCs and impaired HSC-mediated bone
marrow reconstitution in sublethally irradiated mice. Moreover, the effects elicited by ATP were inhibited by suramin, a P2
receptor antagonist, and BAPTA, an intracellular Ca2þ chelator. We further investigated whether the presence of cytokines
might modulate the observed ATP-induced differentiation. Treatment of cells with cytokines (stem cell factor, interleukin-3 and
granulocyte–monocyte colony stimulator factor) before ATP stimulation led to reduced ATP-dependent differentiation in long-
term bone marrow cultures, thereby restoring the ability of HSCs to reconstitute hematopoiesis. Thus, our data suggest that ATP
induces the differentiation of murine HSCs into the myeloid lineage and that this effect can be modulated by cytokines.
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Under steady-state conditions, hematopoietic bone marrow
cells develop in intimate association with a highly organized,
three-dimensional microenvironment. This structural scaffold
is composed of many cell types, including osteoblasts and
stromal cells, as well as their associated biosynthetic
products: components of the extracellular matrix, adhesion
molecules and hematopoietic growth factors.1 The specific
bone marrow microenvironment in which hematopoietic stem
cells (HSCs) reside is referred to as the stem cell niche. HSCs
are a subset of bone marrow cells that are capable of
self-renewal and of forming all types of blood cells.2 The
hematopoietic niche has an essential role in regulating
the self-renewal and differentiation of stem cells. In the bone
marrow, two stem niches have been characterized:
the osteoblastic niche, where osteoblasts primarily control
the quiescence and asymmetric proliferation of HSCs,3 and
the vascular niche, which is mainly associated with myeloid
differentiation.4
The cells present in hematopoietic niches regulate hema-
topoiesis through the release of different cytokines, which
then activate distinct cytokine receptors with intrinsic kinase
activity or Janus kinase-dependent receptors. However, new
families of G-protein-coupled receptors and ion channels
have been recently associated with the regulation of
hematopoiesis,5 such as the P2 receptor family, which is
activated by extracellular nucleotides.6,7 These extracellular
nucleotides are released by endothelial and osteoblast
cells,8–10 and may be associated with myeloid differentiation.6
The functions of ATP are mediated by receptors of the P2
receptor family, which are further divided into the P2X
(ionotropic receptor) and P2Y (metabotropic receptor) sub-
families.11 P2 receptor activation triggers many physiological
responses in various cell types that are mediated by a
Ca2þ influx through the P2X receptor or via intracellular
Ca2þ (Ca2þi ) release by P2Y receptors that activate
phospholipase C (PLC). PLC hydrolyzes phosphatidylinosi-
tol-4,5-bisphosphate and a subsequent increase in inositol
1,4,5-trisphosphate (InsP3) and diacylglycerol (DAG)
occurs.12 In addition, changes in the level of adenylate
cyclase activity have been shown to influence the concentra-
tion of cyclic adenosine monophosphate.13,14 The activation
of P2 receptors controls other intracellular pathways by
changing the concentration levels of Ca2þi and cyclic
adenosine monophosphate, modulating the mitogen-acti-
vated protein kinases and phosphoinositide 3-kinase, both
related with proliferation and differentiation.15,16
In hematopoietic cells, treatment with ATP leads to cellular
activation, with an increase in proinflammatory activities, cell
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death,17,18 platelet aggregation,14 and cellular proliferation
and differentiation.6,7 Studies in promyelocytic leukemia
HL-60 cells have shown that the expression levels of P2
receptors change significantly during myeloid differentia-
tion.19,20 Nucleotides such as ATP and UTP enhance the
response of HSCs to several cytokines.7 For example, UTP
was able to significantly improve chemokine receptor
4-mediated (CxC4R) HSC migration.21 In addition, we have
shown that large increases in ATP-induced Ca2þi promote
transient proliferation and induce the differentiation of
primitive hematopoietic cells in long-term bone marrow
cultures (LTBMCs).6 Recently, the functional presence of
P2X receptors was described in an HSC subset, which is
probably related to proliferation.22
To understand the physiological role of P2 receptors in the
hematopoietic system, the capacity of extracellular ATP to
promote differentiation was investigated in the bone marrow.
Furthermore, the ability of cytokines to inhibit ATP-dependent
differentiation was explored. Our data show that extracellular
ATP induces a reduction in the number of HSCs and myeloid
progenitors (MPs), which leads to an increase of mature
myeloid cells in the bone marrow, and that this effect can be
modulated by the presence of cytokines.
Results
ATP induces changes in the percentage of primitive and
mature bone marrow populations. Because ATP induces
the differentiation of primitive cells in LTBMCs, we
determined whether ATP stimulation could alter the
percentages of the HSC and MP populations, including
the common myeloid progenitors (CMPs), granulocyte–
macrophage progenitors (GMPs) and megakaryocytic–
erythroid progenitors (MEPs). An HSC phenotype was
defined in this study as Linc-KitþSca-1þThy1.1þFlk2, a
subset capable of extensive self-renewal and differentiation
into all types of blood cells.23 Other myeloid progenitors were
recognized as described in previous reports.2,23 The
identification of the populations used in this study is
provided in the Supplementary information (Supplementary
Figure 1). For this purpose, bone marrow cells were
stimulated with ATP at different times and concentrations.
Following stimulation, the samples were labeled to permit the
identification of primitive hematopoietic populations by flow
cytometry. A high concentration of ATP (1mM) was required
to promote different effects in the hematopoietic cells.7,24
However, this concentration did not induce hematopoietic
cell death6,17 (Supplementary Figure 2). Concentrations
lower than 1mM did not induce significant changes in the
percentage of HSCs (Supplementary Figure 3).
Our results showed a significant decrease in the percen-
tage of the HSC (to 44% of untreated levels), CMP (to 28% of
untreated levels) and GMP (to 27% of untreated levels)
populations after stimulation with ATP for 4 h in vitro
(Figure 1a), whereas the MEP population was not affected.
Similar results were obtained by stimulation performed in
short culture for 12 h (Supplementary Figure 4A).
To verify the ATP-induced differentiation, a dose of 0.47g/kg
of ATP was administered in vivo for 4 days. This dose injected
intraperitoneally has been used previously in other studies to
stimulate P2 receptors and did not induce adverse effects
in the treated animals.25,26 After treatment with ATP, bone
marrow cells were collected for immunophenotyping. An
evaluation of the hematopoietic cell populations showed a
significant reduction inGMPs (40%). TheHSC population was
reduced in 35% (of untreated levels), although this did not
constitute a significant decrease, whereas the CMP and MEP
populations were not affected (Figure 1b). Furthermore, an
evaluation of the mature myeloid population (Gr-1þMac-1þ )
from experiments performed in vivo indicated a significant
increase (43%) after 4 days of treatment (Figure 1c).
In additionally, suramin, a P2 antagonist were used to verify
the participation of P2 receptors in the observed effects.
Suramin was able to inhibit the decrease of the hematopoietic
cell populations induced by ATP, both in vivo and in vitro
(Figure 1a and b). Moreover, in the absence of ATP, suramin
did not affect the percentage of hematopoietic populations
(Supplementary Figures 4B and C). Furthermore, adenosine,
which is produced by ATP degradation activating P1
receptors, and xanthine, an adenosine receptor antagonist,
were used to evaluate P1 receptors’ involvement. From our
results, we observed that adenosine did not reduce the
percentage of hematopoietic populations (Supplementary
Figures 5A and B) and that xanthine did not abolish the effect
of ATP in vivo and in vitro (Supplementary Figures 5C and D).
Furthermore, the number of colony-forming units of
granulocytes and macrocytes (CFU-GM) and burst-forming
units-erythroid (BFU-E) was quantified using methylcellulose
assays. ATP induced a 42% reduction in the number of
CFU-GM, but did not alter the number of BFU-E (Figure 1d).
Concentrations lower than 1mM did not induce significant
changes in the percentage of CFU-GM colonies (Supplemen-
tary Figure 6). These data strongly suggest that ATP is
involved in myeloid differentiation, reducing primitive MPs and
increasing their mature forms.
Moreover, as the presence of macrophages in whole bone
marrow could participate indirectly in the effects of differentia-
tion induced by ATP, the same test was conducted with
isolated c-Kitþ cells cultured on the stroma cell line MS5 for
24 h. Similar effects of differentiation in response to ATP were
observed in the absence of macrophages (Figure 1e).
ATP reduces HSC potency. Subsequently, other tests
were performed to verify the ability of ATP to promote
myeloid differentiation, and important features of HSCs were
evaluated, such as exhibiting a quiescent state, Notch
receptor expression and the ability of HSCs to repopulate
the bone marrow. We measure the proliferative state using
an antibody against Ki-67 protein, which is specifically
expressed during all active phases of the cell cycle, but is
absent from resting cells. Stimulation of bone marrow cells
with ATP induced an increase of the HSC-Ki-67þ population
from 20±1 to 46±3%, showing that ATP induces HSC
proliferation (Figure 2a). Notch receptors have been
associated with the self-renewal, quiescence, maintenance
and differentiation of HSC, and its expression is used as an
indicator of the undifferentiated state of HSC.27,28 Stimulation
of bone marrow cells with 1mM ATP for 2 or 4 h led to a
marked reduction in the Notch receptor expression of the
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HSC and MP populations (Figure 2b). In addition, an evaluation
of the competence of HSCs to repopulate the bone marrow
microenvironment after stimulation with 1mM ATP was
performed using transgenic mice expressing the green
fluorescent protein (GFP). Freshly isolated bone marrow cells
from GFP animals were stimulated with ATP for 4h and
immediately injected by retro-orbital injection into sublethally
irradiated (700Gy) wild-type animals. After 8 weeks, the animals
were killed, and the frequency of GFPþ cells within the different
hematopoietic populations was determined. The hematopoietic
populations from the ATP-stimulated group showed a clear
reduction in the frequency of GFPþ cells compared with
controls, indicating a decrease in the ability of ATP-treated
HSCs to reconstitute the hematopoietic system (Figure 2c).
Furthermore, the expression of CxCR4 and calcium-sensing
receptors (CaSR), which are homing receptors of HSCs, were
evaluated. Stimulation of bone marrow cells in vitro did not alter
CxCR4 or CaSR expression (Supplementary Figures 7A and B).
Osteoblastic and endothelial niches regulate the quiescent
state of HSCs. Therefore, if ATP induces HSC differentiation,
then it will likely result in a high level of expression of
ectonucleotidases in hematopoietic progenitors (HPs) and
osteoblast cells. The expression of CD39 and CD73, which
hydrolyze ATP into ADP and AMP into adenosine, respec-
tively, was analyzed in freshly isolated bone marrow cells.
HSC, HP and stromal cells express CD39 and CD73
(Supplementary Figures 7C–F). Moreover, activity of
ectonucleotidases was compared among three populations:
immature hematopoietic population (c-Kitþ cells), stromal
cells (CD45Ter-119) and mature cells of bone marrow
(whole bone marrow cells). We observed that immature
hematopoietic cells exhibit a higher ectonucleotidase activity
than mature or stromal cells (Supplementary Figure 8).
ATP promotes increased [Ca2+]i in hematopoietic
cells. The observed ATP-induced differentiation in
LTBMCs is related to a large increase in Ca2þi .
6 To verify
that the differentiation of primitive bone marrow
hematopoietic cells is dependent on Ca2þi signaling, initial
measurements of Ca2þi were carried out in freshly isolated
Figure 1 ATP decreases the percentages of murine primitive hematopoietic cell populations. (a) Bone marrow suspensions were stimulated with 1mM ATP for 4 h, and
the hematopoietic populations present were quantified, n¼ 6. Hematopoietic stem cell (HSC), common myeloid progenitor (CMP) and granulocyte–macrophage progenitor
(GMP) populations were reduced by stimulation with ATP, whereas megakaryocytic–erythroid progenitors (MEPs) were not affected. (b and c) Mice were treated in vivo with
ATP (47mg/kg) for 4 days, n¼ 6. (b) ATP significantly reduces the GMP population (c) and increases the number of mature myeloid cells (Gr-1þMac-1þ ). (a–c) The effects
induced by ATP were abolished in the presence of suramin, a P2 receptor antagonist. (a) In vitro experiment: suramin 100mM. (b and c) In vivo experiment: suramin 10mg/ml.
(d) c-KitþLin cells were plated in methylcellulose in the presence or absence of 1 mM ATP, n¼ 4. ATP was able to partially reduce the number of CFU-GM colonies. (e) In
addition, the same experiment shown in (a) was performed with an isolated c-KitþLin population on the stroma cell line MS5. Similar results were obtained under these
conditions, n¼ 4. Data are expressed as the mean±S.E.M. *,#Po0.05. *Statistical analysis was performed against a control. #Statistical analysis was performed against
samples stimulated with ATP. (a, b and c) ANOVA test. (d and e) t-test
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HSC and c-KitþLin populations (a population that contains
HPs). After separation, the cells were loaded with the Ca2þ
indicator Fluo-4-AM, and the emission of fluorescence was
visualized by confocal microscopy. The Ca2þi concentration
was represented as a temporal insensitive graph or as
representative pseudocolored images. As shown in
Figure 3a, ATP promoted a transient increase in the
Ca2þi concentration in both primitive populations. Then, the
Ca2þi chelator BAPTA-AM was used to verify the
participation of Ca2þi in ATP-induced differentiation.
BAPTA-AM was incubated with fresh bone marrow cells for
1 h before stimulus with ATP. The Ca2þi chelator was able to
abolish the in vitro ATP-induced differentiation.
Cytokines modulate the observed ATP-induced
differentiation. Cytokines and ATP may be released by
cells in hematopoietic stem cell niches. Thus, these
molecules may regulate HSC activity together. We
investigated whether the presence of cytokines could
modulate the differentiation induced by ATP. For this
purpose, known differentiation effects of ATP were induced
to evaluate whether the previous stimulation of cytokines
altered the response to ATP.
First, we evaluated whether the addition of cytokines could
alter the ATP-dependent increase in the Ca2þi concentration
because the effects of ATP-dependent differentiation occur
mainly via increased Ca2þi (Figure 3). We observed that a
previous 5min stimulation with cytokines (granulocyte–
monocyte colony stimulator factor (GM-CSF), interleukin-3
(IL-3) and stem cell factor (SCF) at 10 ng/ml) partially reduced
the ATP-dependent increase in the Ca2þi concentration in
LTBMCs. The Ca2þi concentration was represented as a
graph of fluorescence intensity versus time or as pseudocolor
images. Representative images are shown in Figure 4a and
the temporal Ca2þi concentration values are shown in
Figure 4b. The increase in Ca2þi was normalized using the
Ca2þ ionophore A23187 (Response 100%). A23187 forms
membrane channels that allow the passage of Ca2þ to the
cytoplasm.
Second, we determined whether cytokines could prevent
ATP-dependent differentiation in LTBMCs, as reported pre-
viously.6 LTBMCs were incubated with GM-CSF, SCF and IL-
3 for 5min and subsequently stimulated with ATP (1mM). The
cells were collected after 3 days of stimulation, and the
percentages of the different populations were analyzed by
flow cytometry. Our results showed that the presence of
cytokines (10 ng/ml) abolished the increase in the mature
myeloid population (Gr-1þMac-1þ ) elicited by 1mM ATP
(Figure 5a). The presence of cytokines also inhibited the ATP-
dependent decrease in primitive cells (Gr-1Mac-1c-Kitþ ) in
LTBMCs (Figure 5b). In addition, Giemsa/May–Gru¨nwald
staining was performed to corroborate the flow cytometry
Figure 2 ATP decreases the undifferentiated characteristics of hematopoietic stem cells (HSCs). (a) Stimulation of bone marrow cells with ATP for 4 h induces an increase
of Ki-67 expression in HSCs. (b) A reduction in Notch expression was observed after ATP treatment. The graphs are representative of three independent experiments. Open
histogram: unstimulated sample. Filled histogram: stimulated sample. (c) Bone marrow cells from green fluorescent protein (GFP) mice were stimulated with 1 mM ATP for 4 h
and transferred to non-lethally irradiated mice. After 8 weeks, the animals that received GFPþ cells were killed, and the percentage of GFPþ cells was quantified in each
population: HSCs, hematopoietic progenitors (HPs), myeloid progenitors (MPs) and the mature myeloid population (Gr-1þMac-1þ ). The stimulation of hematopoietic cells
with ATP led to a decrease in the capacity of HSCs to reconstitute bone marrow. (a and c) Data are expressed as the mean±S.E.M. *Po0.05, (a and c) t-test. n¼ 5–7
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results. The counts of different cell types in the LTBMCs
indicated a reduction in the number of the immature and blast
forms induced by ATP in LTBMCs, and this effect was
inhibited in the presence of cytokines (Table 1).
Finally, we determined whether previous stimulation
with cytokines would prevent the ATP-dependent decrease
in the HSC reconstitution capacity. Thus, bone marrow cells
from GFPþ animals were incubated for 5min with GM-CSF
(10ng/ml) and IL-3 (10 ng/ml) before stimulation with ATP for
4 h. These cells were then injected into sublethally irradiated
animals. After 8 weeks, the bonemarrow cells were extracted,
and the percentages of GFPþ cells within different hemato-
poietic populations were calculated. As shown in Figure 6,
pretreatment with cytokines followed by 4 h of stimulation with
ATP led to a recovery in the reconstitution ability of HSCs. A
significant increase in GFPþ cells was observed within the
immature population (HSC, HP and MP) and the mature
myeloid population (Gr-1þMac-1þ ) compared with the group
treated with ATP alone.
Discussion
Under physiological conditions, HSCs exhibit a quiescent
state and asymmetric proliferation following an interaction
with particular osteoblasts in the trabecula bone area. In
contrast, myeloid differentiation occurs adjacent to blood
vessels.3,4 In addition, some types of unidentified osteoblast
and endothelial cells can release ATP in response to certain
stimuli or physiological conditions.8–10
ATP released by the endothelium or by osteoblasts could
participate in myeloid differentiation. In a previous report, we
showed that ATP and its analogs could induce the transient
proliferation and myeloid differentiation of primitive HPs
present in LTBMCs through the activation of P2 receptors.6
Figure 3 ATP promotes a decrease of primitive hematopoietic populations via intracellular Ca2þ (Ca2þi ). (a) Hematopoietic cells were isolated and incubated with the
Ca2þ fluorophore Fluo-4-AM (10 mM), and images were captured using confocal microscopy. Confocal images are shown with pseudocolor according to a fluorescence
intensity scale (0¼ blue; 255¼ red). The records of fluorescence intensity as a function of time correspond to the images shown on the right. Each line represent the
Ca2þi concentration of an individual cell. ATP increased Ca
2þ
i in hematopoietic stem cells (HSCs) and Lin-c
Kitþ cells in a transient manner. Data are representative of at
least three experiments. (b) Bone marrow suspensions were stimulated with 1 mM ATP for 4 h, and the hematopoietic populations present were quantified. BAPTA (1,2-bis(o-
aminophenoxy)ethane-N,N,N0,N0-tetraacetic acid)-AM (10 mM) was incorporated into the cells for 1 h. The reduction in the number of HSCs, common myeloid progenitor
(CMPs) and granulocyte–macrophage progenitors (GMPs) by ATP was abolished in the presence of the Ca2þi chelator BAPTA. *
,#Po0.05. *Statistical analysis was
performed against a control. #Statistical analysis was performed against samples stimulated with ATP. ANOVA test. n¼ 4
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In light of these findings, this study was undertaken to
investigate the ability of extracellular ATP to induce direct
differentiation of HSC and MPs in vivo and in vitro assays.
Initially, we determined the percentage of HSCs and
myeloid precursor cells (CMP, GMP and MEP) after stimula-
tion with ATP in freshly isolated bone marrow cells. The
percentages of the HSC, CMP and GMP populations present
in the bone marrow were reduced by stimulation with ATP,
whereas the MEP population remained unchanged
(Figure 1a). Subsequently, in vivo experiments showed that
treatment with ATP for 4 days led to a reduction in the number
of MPs (Figure 1b) and a corresponding increase in the
mature myeloid population (Figure 1c). To determine whether
the observed changes in blood cell populations were
associated with differentiation, we evaluated different HSC
characteristics. The presence of a quiescent state, which is a
characteristic of HSCs,2 was evaluated. ATP was able to
reduce the number of HSCs in quiescent state (Figure 2a). In
addition, we investigated whether ATP could alter the
expression the receptors Notch, CxCR4 and CaSR. Notch
receptors have been associated with the self-renewal,
quiescence, maintenance and differentiation of HSCs, and
Figure 4 Cytokines partially inhibit the ATP-induced intracellular Ca2þ concentration ([Ca2þ ]i) increase in long-term bone marrow cultures (LTBMCs). LTBMCs were
incubated with the Ca2þ fluorophore Fluo-4-AM (10 mM), and images were captured using confocal microscopy. LTBMCs were stimulated with 1 mM ATP in the presence or
absence of cytokines (granulocyte–monocyte colony stimulator factor (GM-CSF), stem cell factor (SCF) and interleukin-3 (IL-3): 10 ng/ml). (a) Confocal images are shown with
pseudocolor according to a fluorescence intensity scale (0¼ black; 255¼white). Representative images of basal [Ca2þ ]i intensity and the intensity following ATP stimulation
and administration of the Ca2þ ionophore A23187 are shown. Control corresponds to the response without previous stimulation with cytokines. The records of fluorescence
intensity as a function of time correspond to the images shown on the right. The trace is a mean of 10–20 cells. (b) The average increase in the Ca2þi concentration elicited by
ATP. The increase in [Ca2þ ]i was normalized using the Ca
2þ ionophore 106 M A23187 (Response 100%). Data are expressed as the mean±S.E.M. *Po0.05. ANOVA
test. n¼ 4–5
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their expression is used as an indicator of the undifferentiated
state of HSCs,27–29 whereas CxCR4 and CaSR are homing
receptors required for the colonization of bone marrow by
HSCs during the development of hematopoiesis.30,31 ATP
reduced the expression of Notch receptors (Figure 2b).
However, there was no observed alteration in the expression
of CxCR4 or CaSR (Supplementary Figures 7A and B).
Moreover, ATP reduced the ability of HSCs to reconstitute
important characteristics of HSC potency in bone marrow
(Figure 2c). Therefore, we have showed that ATP reduces the
HSC and primitive macrophage/granulocytic progenitor po-
pulations, leading to an increase of the mature myeloid
population.
Our results showed that the observed ATP-induced
differentiation occurred by P2 receptor activation. Participa-
tion of the P2 receptor was shown using suramin, a well-
known P2 antagonist, in vitro and in vivo experiments
(Figure 1). On the other hand, the participation of P1
receptors, activated by adenosine, was excluded by the use
of adenosine and xanthine, a P1 receptor inhibitor (Supple-
mentary Figure 5). However, the identification of the P2
receptor subtypes deserves further investigation.
In addition, the maintenance of HSCs in a quiescent state in
the osteoblast niche can also be related to a high level of
ectonucleotidase expression, including that of CD39 and
CD73 (Supplementary Figures 7C–F). Interestingly, primitive
hematopoietic cells, characterized as c-Kitþ cells, showed
higher ectonucleotidase activity than stromal cells andmature
hematopoietic cells (whole bone marrow) (Supplementary
Figure 8). These results could explain the lower differentiation
effect caused by ATP in vivo assay (Figure 1b). It is possible
that the high expression and activity of HSC and stromal cells
reduced the differentiation induced by ATP in the hemato-
poietic niche. Hence, the expression and activity of ectonu-
cleotidases arises like a new important feature to
undifferentiated state. However, further investigation on the
role of ectonucleotidases in hematopoietic differentiation is
needed.
On the other hand, the signaling pathways involved in the
differentiation by the activation of P2 receptors have not been
completely elucidated. In fact, Ca2þi signaling is the main
intracellular pathway triggered by P2 receptors and we have
shown its participation in the differentiation induced by ATP.
Ca2þ is a ubiquitous messenger that controls many physio-
logical cellular processes in different tissues, including the
cells of the bone marrow microenvironment.6,32 Our results
show that ATP induces an increase in Ca2þi in HSC and
c-KitþLin populations (Figure 3a) and that this differentiation
is Ca2þi dependent (Figure 3b). The involvement of Ca
2þ in
cytokine-mediated signaling was recently reported by our
group.33 However, the molecular mechanisms stimulated by
Ca2þi to carry out the response to ATP and cytokines remain
unknown. The Ca2þi increase elicited by ATP is large and
transiently induced in the cells studied here (Figure 3a). In
contrast, the change in Ca2þi elicited by cytokines exhibits a
short and oscillatory signal.6,33 Ca2þ signaling stimulated by
signaling molecules can influence proliferation, differentiation
and cell death, and the response to Ca2þ signaling is
determined by proteins that are sensitive to the intensity and
duration of the Ca2þ signal.32 It is known that activation of
PLCg, an enzyme that hydrolyzes phosphatidylinositol 4,5-
bisphosphate to generate the two second messengers, InsP3
and DAG, and cytosolic Ca2þ modulate several important
Figure 5 Cytokines inhibit ATP-induced differentiation in long-term bone
marrow cultures (LTBMCs). LTBMCs were incubated for 24 h in Iscove’s modified
Dulbecco’s medium (IMDM) medium supplemented with 0.5% fetal bovine serum
(FBS) before stimulation with ATP in the presence or absence of cytokines
(granulocyte–monocyte colony stimulator factor (GM-CSF), stem cell factor (SCF)
and interleukin-3 (IL-3): 10 ng/ml). The percentages represented in each histogram
were obtained 3 days after stimulation with or without cytokines. Cytokines were
added 5min before stimulation with ATP. (a) Analysis of LTBMC populations
showed that cytokines inhibit the increase of the mature Gr-1þMac-1þ population.
(b) The ATP-induced decrease in primitive hematopoietic populations (Gr-1Mac-
1c-Kitþ ) was abolished in the presence of cytokines in LTBMCs. Data are
expressed as the mean±S.E.M. *Po0.05. ANOVA test. n¼ 6–8
Table 1 Statistical analysis of populations present in LTBMCs was performed
following stimulation with ATP in the presence or absence of cytokines (IL-3,
GM-CSF and SCF at 10 ng/ml) after 3 days
Macro-
phages
Mono-
cytoids
Neu-
trophils
Immature
forms
Blasts
Control 28±3* 29±4 22±2 18±1 3±1
IL-3 38±2 24±2 16±3 18±3 4±2
GM-CSF 40±4 26±3 20±4 12±3 2±1
SCF 38±2 21±1 11±2 18±1 12±4
ATP 80±4* 12±3* 4±1* 3±1* 1±0.5*
IL-3+ATP 52±2# 10±2 18±2# 15±4# 5±2#
GM+ATP 54±2# 8±1 23±3# 12±1# 3±1
SCF+ATP 48±1# 9±2 11±2# 24±2# 8±3#
The cells were stained with May–Gru¨nwald and Giemsa solutions. Data are
expressed as means±S.E.M. *,#Po0.05. *Statistical analysis was performed
against a control. #Statistical analysis was performed against samples
stimulated with ATP. ANOVA test. n¼ 6–8
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transcription factor pathways required for the development or
differentiation of B cells.34 In myeloid differentiation, the
participation of PLCg2 by the activation of cytokines receptors
was described recently.33 Moreover, an unidentified PLCb is
activated by ATP in HSC, which produces InsP3 and DAG
similarly to PLCg. These two PLC isoforms can modulate
hematopoiesis depending on the amount of Ca2þi released.
Therefore, the increase in Ca2þi levels elicited by ATP or
cytokines leads to different cellular effects because distinct
Ca2þ -sensitive proteins could be activated.
The presence of ATP in hematopoietic niches can be an
important factor in regulating HSC activity together with other
signaling molecules that regulate hematopoiesis, such as
cytokines. Here, we show that the presence of cytokines can
modulate ATP-induced differentiation. Previous stimulation of
LTBMCs with cytokines reduced the effects of ATP-depen-
dent Ca2þi increases (Figure 4) and hematopoietic differ-
entiation (Figure 5). Finally, previous incubation with
cytokines also restored the ability of HSCs to repopulate
bone marrow after non-lethal irradiation (Figure 6). Therefore,
the intracellular pathways induced by ATP led to differentia-
tion, whereas at the same time, cytokines and other signals
activate specific pathways that regulate the maintenance
of HPs.
Cytokines activate several intracellular mechanisms that
could prevent some overload responses. GM-CSF was able
to reduce cell death by activation of chimeric receptor
GM-CSF-Bcl-XL protein.35 In addition, moderate elevation
of Ca2þi concentration also induces cytokine-independent
survival and proliferation of human myelo-erythroid CD34þ
leukemia cell line.36. The low increase of Ca2þi concentration
by cytokines probably activates the mechanism related with
survival decreasing the ATP-induced differentiation.
The results of this study show that extracellular ATP
decreases HSC and MPs populations, promoting myeloid
differentiation. Moreover, we showed that cytokines are able
to modulate ATP-induced differentiation. These findings are
important for understanding the HSC niche and point out the
importance of the ATP and the P2 receptors in the
hematopoiesis.
Materials and Methods
Animals. The wild-type mice (C57BL/6, 8–12 weeks old) used in this study were
supplied by the INFAR/UNIFESP Animal Facility (Sa˜o Paulo, Brazil), and the GFP
mice (C57BL/6-Tg(act-EGFP)C14-Y01-FM131Osb) were maintained at CEDEME/
UNIFESP. All experiments were approved by the Animal Care and Ethics
Committee of the Federal University of Sa˜o Paulo (0254/08).
In vivo assays. Solutions of nucleotides in saline were prepared as described by
Rapaport.26 Briefly, 0.47 g/kg of ATP was diluted in saline (sterile saline, pH 6.2) and
intraperitoneally injected daily for 4 days. A control group received an equivalent
volume of the vehicle daily (sterile saline) by intraperitoneally injection.25,26 In some
experiments, 10mg/kg suramin37 and 3 mg/kg xanthine38 were applied 1 h before to
ATP injection.
Quantification of hematopoietic populations. Bone marrow cells
were extracted from femurs and stimulated with ATP at 371C for 4 h. All experiments
up to 4 h were performed in a physiological solution (137mM NaCl, 2.68mM KCl,
1.36mM CaCl2, 0.49mM MgCl2, 12mM NaHCO3, 0.36 mM NaH2PO4, and 5.5 mM
D-glucose). For experiments more than 12 h long, Iscove’s modified Dulbecco’s
medium (IMDM) supplemented with 2% fetal bovine serum (FBS) was used.
Cells were stimulated, and the percentages of each hematopoietic population were
Figure 6 Cytokines recover the reconstitution capacity of hematopoietic stem cells (HSCs). Bone marrow cells extracted from green fluorescent protein (GFP) mice were
stimulated with 1 mM ATP for 4 h and transferred to non-lethally irradiated mice. After 8 weeks, the animals were killed, and the percentage of GFPþ cells were quantified in
each hematopoietic population: (a) HSCs, (b) hematopoietic progenitors (HPs), (c) myeloid progenitors (MPs) and (d) the mature myeloid population (Gr-1þ
Mac-1þ ). Pre-incubation with cytokines restores HSC potency after ATP stimulation. Data are expressed as the mean±S.E.M. *,#Po0.05. *Statistical analysis was
performed against a control. #Statistical analysis was performed against samples stimulated with ATP. ANOVA test. n¼ 5–7
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determined by flow cytometry and compared with the initial percentage. HP cells
were identified as described previously.2,23 Mature cells were excluded using a
lineage marker cocktail (Lin: PE-conjugated B220, CD3, Ter-119, CD11b and Gr-1).
In addition, several antibodies (FLK-2-PE, IL-7R-PE, CD90-FITC, Sca-1-Cy7/PE
and c-Kit-APC) were used to recognize a subset rich in HSCs (LinFLK-2Sca-
1þ c-KitþThy1.1þ or LinFLK-2Sca-1þ c-Kitþ ); HP (LinSca-1c-Kitþ ), a
population that contained myeloid and lymphoid progenitors; and MP (LinSca-
1IL-7c-Kitþ ). Moreover, CMP (LinIL-7Rc-KitþSca-1CD34þFcgRlow), GMP
(LinIL-7Rc-KitþSca-1CD34þFcgRhigh) and MEP (LinIL-7Rc-KitþSca-
1CD34FcgRlow) populations were identified using IL-7R-PE, Sca-1-PE, c-Kit-
Cy7/PE, CD34-FITC and FCgR-APC antibodies. To quantify the percentage of
hematopoietic populations, 3–5 106 events were acquired. All antibodies were
purchased from Becton Dickinson (Franklin Lakes, NJ, USA) or eBioscience (San
Diego, CA, USA). The mature bone marrow-resident myeloid populations were
evaluated with antibodies that recognize granulocytic and monocytic populations
(Gr-1-PE and CD11b-Cy7/PE, respectively). We captured 3 000 000 events to
evaluate this mature population. Data analyses were performed on a FACSCalibur
(Becton Dickinson) flow cytometer using the CellQuest software. The gating
strategy for murine hematopoietic populations is shown in Supplementary Figure 1.
Murine Linc-Kitþ and CFU-GM assay. Separation of the murine Linc-
Kitþ population was performed by gradient centrifugation methods using Ficoll
Histopaque (1.077 g/cm3). After mononuclear isolation, the cells were labeled with
specific antibodies. For cell isolation, a biotin-conjugated Lin antibody cocktail was
used, followed by incubation with anti-biotin-conjugated microbeads (Miltenyi
Biotec, Columbus, OH, USA). After labeling, the cells were placed in a magnetic
column, and the negative population was extracted. The Lin cells were labeled
with anti-c-Kit-conjugated microbeads (Miltenyi Biotec), and the Linc-Kitþ
population was isolated in a magnetic column.
CFU assays were performed by plating 5 103 murine (Linc-Kitþ ) bone
marrow cells in methylcellulose-based medium with recombinant cytokines and
EPO (Methocult M3434; Stem Cell Technologies, Vancouver, Canada) in 35-mm
diameter dishes. The cells were cultured in a fully humidified air incubator under 5%
CO2 at 371C for 7 or 14 days for murine and human cells, respectively. At the end of
the incubation period, colonies of more than 50 cells were counted using a dark-field
microscope.
Notch and Ki-67 expression. Bone marrow cells were stimulated with ATP
at 371C for 2 or 4 h in a physiological solution. Subsequently, cells were fixed with
2% paraformaldehyde for 30min, washed with 0.1 M glycine and permeabilized with
0.01% saponin for 15min. The cells were incubated for 2 h with rabbit purified anti-
Notch-1 or anti-Ki-67-Alexa Fluor-488 conjugated (Becton Dickinson). Anti-rabbit
IgG-Alexa Fluor 488 conjugates (Molecular Probes/Invitrogen, Eugene, OR, USA)
was used as secondary antibody against anti-Notch-1 and incubated for 40min.
Notch and Ki-67 expression were evaluated in hematopoietic populations using the
antibodies described above. Data analyses were performed on a FACSCalibur flow
cytometer using the CellQuest software.
Competitive repopulation assay. Whole bone marrow cells of GFP
transgenic mice were stimulated with 1 mM ATP in the presence or absence of GM-
CSF (10 ng/ml) and IL-3 (10 ng/ml) in physiological solution at 371C for 4 h and then
injected (106 cells per animal) into wild-type sublethally irradiated mice (700 Gy).
The frequency of GFPþ bone marrow cells in each hematopoietic population (HSC,
HP, MP and Gr-1þMac-1þ ) was quantified at 8 weeks post-transfer using a
FACSCalibur flow cytometer.
Dexter-type cultures. Dexter-type cultures or LTBMCs were prepared
following the method of Dexter et al.39 with some modifications. Briefly, total
bone marrow cells were plated onto 12-well plates and fed weekly with IMDM
supplemented with 5% FBS (Cultilab, Rio Grande do Sul, Brazil), 20% horse serum
(Stemcell Technologies) and 106 M hydrocortisone (Sigma-Aldrich, St Louis, MO,
USA). Cultures were maintained at 371C in a humid chamber with 5% CO2. After the
establishment of a confluent stroma layer, the remaining non-adherent cells were
removed, and 106 cells per well was added to precultured stroma cultures, along
with fresh media. After 1 week of co-culture, the cells were further cultured in IMDM
with 0.5% FBS for 24 h. Subsequently, LTMBCs were stimulated with ATP in the
presence or absence of IL-3, GM-CSF and SCF. After 3 days, the cells were
collected for immunophenotyping using the antibodies Gr-1-FITC, Mac-1-PE and
c-Kit-APC. Data analyses were performed on a FACSCalibur flow cytometer
(Becton Dickinson). In addition, co-cultured cells were stained with May–Gru¨nwald
and Giemsa solution (Sigma) and identified by morphological characteristics.
Calcium measurements by confocal microscopy. Linc-Kitþ and
HSC populations were previously isolated to measure Ca2þi . The Lin
 cells were
isolated as described above. HSC isolation was performed by cell sorting in a
FACSCalibur flow cytometer.
After the separation of populations, the cells were cytocentrifuged onto glass
coverslips (25mm). For intracellular Ca2þ concentration ([Ca2þ ]i) measurements,
the isolated cells or LTBMCs were incubated for 40min at room temperature with
10mM Fluo-4/AM (Molecular Probes/Invitrogen) and 0.01% pluronic acid (Molecular
Probes/Invitrogen) and washed with physiological solution. Images were captured
with a microscope (Zeiss, Axiovert 100M, Oberkochen, Germany) equipped with
a laser scanner (Zeiss, LSM 510 META) and a 63 objective (Plan-Neofluor, 1.4
numerical aperture) under oil immersion. The Fluo-4 probe was excited with
an argon laser (lEx¼ 488 nm), and light emission was detected using a Zeiss
META detector (lEm¼ 500–550 nm). The pinhole device was not used for
Ca2þi measurements. Images were collected at approximately 4- to 6-s intervals.
Fluorescence intensity was normalized with reference to basal fluorescence using
the Examiner 3.2 (Zeiss) and Spectralyzer (NJ, USA) software. Representative
pseudocolored images are shown with reference to the basal intensity on a
fluorescence intensity scale ranging from 0 (black or blue) to 255 (white or red).
Statistical analysis. Ca2þ mobilization in response to ATP was normalized
with reference to the response to 106 M A23187 (100%), and results were
presented as representative pseudocolored images according to a fluorescence
intensity scale. Data were expressed as means±S.E.M. Statistical analyses were
performed using Student’s t-test for comparisons between two groups, and analysis
of variance and Dunnett’s post hoc test were used for multiple comparisons among
groups. Values of Po0.05 were considered statistically significant.
Conflict of Interest
The authors declare no conflict of interest.
Acknowledgements. This work was supported by grants from the ‘Fundac¸a˜o
de Amparo a` Pesquisa do Estado de Sa˜o Paulo’ (FAPESP). CMVB was supported
by a doctoral fellowship from FAPESP (2007/58589-9).
1. Nilsson SK, Johnston HM, Coverdale JA. Spatial localization of transplanted hemopoietic
stem cells: inferences for the localization of stem cell niches. Blood 2001; 97: 2293–2299.
2. Passegue E, Wagers AJ, Giuriato S, Anderson WC, Weissman IL. Global analysis of
proliferation and cell cycle gene expression in the regulation of hematopoietic stem and
progenitor cell fates. J Exp Med 2005; 202: 1599–1611.
3. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG et al. Identification of the haematopoietic
stem cell niche and control of the niche size. Nature 2003; 425: 836–841.
4. Yin T, Li L. The stem cell niches in bone. J Clin Invest 2006; 116: 1195–1201.
5. North TE, Goessling W, Walkley CR, Lengerke C, Kopani KR, Lord AM et al. Prostaglandin
E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 2007; 447:
1007–1011.
6. Paredes-Gamero EJ, Leon CM, Borojevic R, Oshiro ME, Ferreira AT. Changes in
intracellular Ca2+ levels induced by cytokines and p2 agonists differentially modulate
proliferation or commitment with macrophage differentiation in murine hematopoietic cells.
J Biol Chem 2008; 283: 31909–31919.
7. Lemoli RM, Ferrari D, Fogli M, Rossi L, Pizzirani C, Forchap S et al. Extracellular
nucleotides are potent stimulators of human hematopoietic stem cells in vitro and in vivo.
Blood 2004; 104: 1662–1670.
8. Kawai Y, Yokoyama Y, Kaidoh M, Ohhashi T. Shear stress-induced ATP-mediated
endothelial constitutive nitric oxide synthase expression in human lymphatic endothelial
cells. Am J Physiol Cell Physiol 2010; 298: C647–C655.
9. Alvarenga EC, Rodrigues R, Caricati-Neto A, Silva FC, Paredes-Gamero EJ, Ferreira AT.
Low-intensity pulsed ultrasound-dependent osteoblast proliferation occurs by via activation
of the P2Y receptor: role of the P2Y(1) receptor. Bone 2010; 46: 355–362.
10. Hayton MJ, Dillon JP, Glynn D, Curran JM, Gallagher JA, Buckley KA. Involvement of
adenosine 50-triphosphate in ultrasound-induced fracture repair. Ultrasound Med Biol
2005; 31: 1131–1138.
11. Abbracchio MP, Burnstock G. Purinoceptors: are there families of P2X and P2Y
purinoceptors? Pharmacol Ther 1994; 64: 445–475.
Myeloid differentiation by ATP
CMV Barbosa et al
9
Cell Death and Disease
12. Nicholas RA, Lazarowski ER, Watt WC, Li Q, Boyer J, Harden TK. Pharmacological and
second messenger signalling selectivities of cloned P2Y receptors. J Auton Pharmacol
1996; 16: 319–323.
13. Suh BC, Kim TD, Lee IS, Kim KT. Differential regulation of P2Y(11) receptor-mediated
signalling to phospholipase C and adenylyl cyclase by protein kinase C in HL-60
promyelocytes. Br J Pharmacol 2000; 131: 489–497.
14. Takasaki J, Kamohara M, Saito T, Matsumoto M, Matsumoto S, Ohishi T et al. Molecular
cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another
ADP receptor, the P2Y(1) receptor. Mol Pharmacol 2001; 60: 432–439.
15. Giltaire S, Lambert S, Poumay Y. HB-EGF synthesis and release induced by cholesterol
depletion of human epidermal keratinocytes is controlled by extracellular ATP and involves
both p38 and ERK1/2 signaling pathways. J Cell Physiol 2011; 226: 1651–1659.
16. Ornelas IM, Ventura AL. Involvement of the PI3K/AKT pathway in ATP-induced
proliferation of developing retinal cells in culture. Int J Dev Neurosci 2010; 28: 503–511.
17. Paredes-Gamero EJ, Dreyfuss JL, Nader HB, Miyamoto Oshiro ME, Ferreira AT.
P2X7-induced apoptosis decreases by aging in mice myeloblasts. Exp Gerontol 2007; 42:
320–326.
18. Costa-Junior HM, Hamaty FC, da Silva Farias R, Einicker-Lamas M, da Silva MH,
Persechini PM. Apoptosis-inducing factor of a cytotoxic T cell line: involvement of a
secretory phospholipase A2. Cell Tissue Res 2006; 324: 255–266.
19. Communi D, Janssens R, Robaye B, Zeelis N, Boeynaems JM. Rapid up-regulation of P2Y
messengers during granulocytic differentiation of HL-60 cells. FEBS Lett 2000; 475: 39–42.
20. Adrian K, Bernhard MK, Breitinger HG, Ogilvie A. Expression of purinergic receptors
(ionotropic P2X1-7 and metabotropic P2Y1-11) during myeloid differentiation of HL60 cells.
Biochim Biophys Acta 2000; 1492: 127–138.
21. Rossi L, Manfredini R, Bertolini F, Ferrari D, Fogli M, Zini R et al. The extracellular
nucleotide UTP is a potent inducer of hematopoietic stem cell migration. Blood 2007; 109:
533–542.
22. Casati A, Frascoli M, Traggiai E, Proietti M, Schenk U, Grassi F. Cell-autonomous
regulation of hematopoietic stem cell cycling activity by ATP. Cell Death Differ 2011; 18:
396–404.
23. Christensen JL, Weissman IL. Flk-2 is a marker in hematopoietic stem cell differentiation: a
simplemethod to isolate long-term stem cells.Proc Natl Acad Sci USA 2001; 98: 14541–14546.
24. Paredes-Gamero EJ, Craveiro RB, Pesquero JB, Franca JP, Oshiro ME, Ferreira AT.
Activation of P2Y1 receptor triggers two calcium signaling pathways in bone marrow
erythroblasts. Eur J Pharmacol 2006; 534: 30–38.
25. Shabbir M, Thompson C, Jarmulowiczc M, Mikhailidis D, Burnstock G. Effect of
extracellular ATP on the growth of hormone-refractory prostate cancer in vivo. BJU Int
2008; 102: 108–112.
26. Rapaport E. Experimental cancer therapy in mice by adenine nucleotides. Eur J Cancer
Clin Oncol 1988; 24: 1491–1497.
27. Duncan AW, Rattis FM, DiMascio LN, Congdon KL, Pazianos G, Zhao C et al. Integration
of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol 2005; 6:
314–322.
28. Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K et al. A role for Wnt
signalling in self-renewal of haematopoietic stem cells. Nature 2003; 423: 409–414.
29. Maillard I, He Y, Pear WS. From the yolk sac to the spleen: new roles for Notch in regulating
hematopoiesis. Immunity 2003; 18: 587–589.
30. Kiel MJ, Morrison SJ. Maintaining hematopoietic stem cells in the vascular niche. Immunity
2006; 25: 862–864.
31. Adams GB, Chabner KT, Alley IR, Olson DP, Szczepiorkowski ZM, Poznansky MC et al.
Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor.
Nature 2006; 439: 599–603.
32. Cook SJ, Lockyer PJ. Recent advances in Ca(2+)-dependent Ras regulation and cell
proliferation. Cell Calcium 2006; 39: 101–112.
33. Leon CM, Barbosa CM, Justo GZ, Borelli P, Resende JDJ, Oliveira JS et al. Requirement
for PLCgamma2 in IL-3 and GM-CSF-stimulated MEK/ERK phosphorylation in murine and
human hematopoietic stem/progenitor cells. J Cell Physiol 2011; 226: 1780–1792.
34. Scharenberg AM, Humphries LA, Rawlings DJ. Calcium signalling and cell-fate choice in B
cells. Nat Rev Immunol 2007; 7: 778–789.
35. Antignani A, Youle RJ. The cytokine, granulocyte-macrophage colony-stimulating factor
(GM-CSF), can deliver Bcl-XL as an extracellular fusion protein to protect cells from
apoptosis and retain differentiation induction. J Biol Chem 2007; 282: 11246–11254.
36. Apati A, Janossy J, Brozik A, Bauer PI, Magocsi M. Calcium induces cell survival and
proliferation through the activation of the MAPK pathway in a human hormone-dependent
leukemia cell line, TF-1. J Biol Chem 2003; 278: 9235–9243.
37. Yang DM, Teng HC, Chen KH, Tsai ML, Lee TK, Chou YC et al. Clodronate-induced cell
apoptosis in human thyroid carcinoma is mediated via the P2 receptor signaling pathway.
J Pharmacol Exp Ther 2009; 330: 613–623.
38. Mino RP, Spoerri PE, Caballero S, Player D, Belardinelli L, Biaggioni I et al. Adenosine
receptor antagonists and retinal neovascularization in vivo. Invest Ophthalmol Vis Sci
2001; 42: 3320–3324.
39. Dexter TM, Allen TD, Lajtha LG. Conditions controlling the proliferation of haemopoietic
stem cells in vitro. J Cell Physiol 1977; 91: 335–344.
Cell Death and Disease is an open-access journal
published by Nature Publishing Group. This work is
licensed under the Creative Commons Attribution-Noncommercial-No
Derivative Works 3.0 Unported License. To view a copy of this license,
visit http://creativecommons.org/licenses/by-nc-nd/3.0/
Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)
Myeloid differentiation by ATP
CMV Barbosa et al
10
Cell Death and Disease
